Advertisement Plethora Solutions Introduces New Drug For Male Sexual Health - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Plethora Solutions Introduces New Drug For Male Sexual Health

Plethora Solutions Holdings, a UK-based speciality pharmaceutical company, has introduced hi-Argenol, for the maintenance and improvement of male sexual health.

Plethora said that hi-Argenol is a novel formulation of purified natural ingredients designed specifically to maintain and improve male sexual health including erectile function and fertility.

hi-Argenol is expected to be marketed directly to consumers online through Plethora’s subsidiary company, The Urology Company.

Further, Plethora claimed that the active ingredients in hi-Argenol helps men to produce nitric oxide which acts as a vasodilator and leads to increased blood flow which can further help them to overcome erectile dysfunction.

Plethora added that other ingredients in hi-Argenol contribute to improving fertility and prostate health.

Wallace Dinsmore, consultant at the Royal Victoria Hospital in Belfast, said: “hi-Argenol potentially provides men with an easily-accessible option to maintain their sexual health on an ongoing basis.”

Mike Wyllie, CSO of Plethora, said: “There has been an increasing acceptance and use of natural products in the treatment of urological disease. For example, Serenoa repens has been used by a significant number of men worldwide to manage their symptoms of prostatic disease and it is anticipated that hi-Argenol will be equally popular as an aid to sexual health.”